GLP Watchdog

Push Health vs SkinnyRx

SkinnyRx has an open FDA warning letter dated February 20, 2026. Push Health has none. Push Health publishes no GLP-1 price we could capture. SkinnyRx starts at $248 a month for brand-name semaglutide pill.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Push Health / SkinnyRx

Push Health logo

Push Health

4.1/10

Featured pick (affiliate partner)

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
No GLP-1 price published
$248/moBrand-name semaglutide pill
States
No state list published
47 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit Push Health
Visit SkinnyRx

SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Push Health pays us nothing. The scores are computed the same way for both and are shown as computed (Push Health 4.1, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. Push Health has none.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    Push Health publishes no GLP-1 price we could capture. SkinnyRx starts at $248 a month for brand-name semaglutide pill.

  4. 04

    Only SkinnyRx lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen.

  5. 05

    SkinnyRx lists 47 states. Push Health publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Push Health

SkinnyRx

Compounded semaglutide injection
Not sold or not priced

$99/mo

first month only; not compared

Compounded tirzepatide injection
Not sold or not priced

$99/mo

first month only; not compared

Brand-name semaglutide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Compounded oral semaglutide
Not sold or not priced

$149/mo

first month only; not compared

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Brand-name semaglutide pill
Not sold or not priced

$248/mo

$2,976 a year

Foundayo (orforglipron) pill
Not sold or not priced

$248/mo

$2,976 a year

Price includes
Not stated
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
Full refund if you cancel before the provider writes a prescription; none after
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods

Read off each seller’s own pages. Push Health: September 28, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Push Health

4.1/10
  • No FDA warning letter on record
  • Names no compounding pharmacy
  • Publishes no state list
  • Publishes no GLP-1 price
Visit Push Health

The case for SkinnyRx

6.3/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Push Health does not price
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

Push Health 4.1 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.6

Effectiveness25%

5.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

4.0A
vs
B
2.0

Accessibility10%

5.0A
vs
B
9.5

Support10%

5.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Push Health vs SkinnyRx: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. Push Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Push Health states you can cancel at any time; refunds: full refund if you cancel before the provider writes a prescription; none after. SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Push Health pays us nothing. The scores are computed the same way for both and are shown as computed (Push Health 4.1, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks